首页> 美国卫生研究院文献>Clinical Psychopharmacology and Neuroscience >Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study

【2h】

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study

机译：失眠患者改用优索和联用优索与苯二氮卓受体激动剂的评估：一项回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveSuvorexant is a novel hypnotic drug that does not interact with the conventional γ-aminobutyric acid (GABA)-A receptor. We investigated the method by which suvorexant was introduced in insomnia patients who were taking benzodiazepine receptor agonists (BzRA).

机译：ObjectiveSuvorexant是一种新型催眠药，不与常规γ-氨基丁酸（GABA）-A受体相互作用。我们调查了在服用苯二氮卓类受体激动剂（BzRA）的失眠患者中引入suvorexant的方法。

著录项

期刊名称 Clinical Psychopharmacology and Neuroscience
作者
Masakazu Hatano; Hiroyuki Kamei; Risa Inagaki; Haruna Matsuzaki; Manako Hanya; Shigeki Yamada; Nakao Iwata;
展开▼
作者单位

展开▼
年(卷),期 2018(16),2
年度 2018
页码 184–189
总页数 6
原文格式 PDF
正文语种
中图分类神经科学;
关键词
Suvorexant Orexin receptor antagonists Benzodiazepines Insomnia Adverse effects;

机译：Suvorexant;Orexin受体拮抗剂;苯二氮卓类;失眠;不良反应;

相似文献

外文文献
中文文献
专利

1. Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study [J] . Masakazu Hatano, Hiroyuki Kamei, Risa Inagaki, Clinical Psychopharmacology and Neuroscience . 2018,第2期

机译：失眠患者改用优索和VS联用与苯二氮卓受体激动剂的评估：一项回顾性研究
2. Benefits Associated with Switching from Benzodiazepine Hypnotics to Suvorexant in Elderly Major Depressive Patients with Mild Insomnia [J] . Hidenobu Suzuki, Hiroyuki Hibino, Yuichi Inoue, International medical journal: IMJ . 2018,第3期

机译：与从苯二氮卓催眠症切换到患有轻度失眠的老年人主要抑郁患者的益处催眠
3. Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia [J] . Hidenobu Suzuki, Hiroyuki Hibino, Yuichi Inoue, Asian journal of psychiatry . 2017,第期

机译：与轻度原发性失眠患者的苯二氮卓催眠术中与苯二氮卓催眠催眠相关的益处
4. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
5. Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind crossover study of suvorexant 20 mg versus placebo [O] . Timothy Roehrs, Dana Withrow, Gail Koshorek, 2020

机译：人类患有纤维肌痛和可混合性失眠症的睡眠和疼痛：双盲Suvorexant的交叉研究20毫克与安慰剂
6. 0405 Randomized Controlled Clinical Polysomnography Trial of Suvorexant for Treating Insomnia in Patients with Alzheimer’s Disease [O] . W Joseph Herring, Paulette Ceesay, Ellen Snyder, 2019

机译：0405随机对照临床多核糖组摄制试验Suvorexant治疗阿尔茨海默病患者失眠症

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study

摘要

著录项

相似文献

相关主题

期刊订阅